[1] |
BASHIARDES S,SHAPIRO H,ROZIN S,et al.Non-alcoholic fatty liver and the gut microbiota[J].Molecular Metabolism,2016,5(9):782. |
[2] |
ABENAVOLI L,MILIC N,DI RENZO L,et al.Metabolic aspects of adult patients with nonalcoholic fatty liver disease[J].World J Gastroenterol,2016,22(31):7006. |
[3] |
ZHU JZ,HOLLIS-HANSEN K,WAN XY,et al.Clinical guidelines of non-alcoholic fatty liver disease:a systematic review[J].World J Gastroenterol,2016,22(36):8226. |
[4] |
HSU WF,SHEEN LY,LIN HJ,et al.A review of western and traditional chinese medical approaches to managing nonalcoholic fatty liver disease[J].Evid Based Complement Alternat Med,2016,2016(9):6491420. |
[5] |
WANG XL,LIU ZP,WANG K,et al.Additive effects of the risk alleles of PNPLA3 and TM6SF2 on nonalcoholic fatty liver disease(NAFLD) in a Chinese population[J].Front Genet,2016,7:140. |
[6] |
KÖROǦLU E,CANBAKAN B,ATAY K,et al.Role of oxidative stress and insulin resistance in disease severity of non-alcoholic fatty liver disease[J].Turk J Gastroenterol,2016,27(4):361. |
[7] |
WANG X,LIU Z,WANG K,et al.An animal model for the juvenile non-alcoholic fatty liver disease and non-alcoholic steatohepatitis[J].PLoS One,2016,11(7):e0158817. |
[8] |
MARCHESINI G,BUGIANESI E,FORLANI G,et al.Nonalcoholic fatty liver,steatohepatitis,and the metabolic syndrome[J].Hepatology,2003,37(4):917. |
[9] |
YU J,MARSH S,HU J,et al.The pathogenesis of nonalcoholic fatty liver disease:interplay between diet,gut microbiota,and genetic background[J].Gastroenterol Res Pract,2016(2016):ID2862173. |
[10] |
葛麟,谭正怀,唐大轩,等.轻肝颗粒对小鼠非酒精性脂肪肝的作用研究[J].中药药理与临床,2009,25(2):94. |
[11] |
南月敏,王蕾,李良宵,等.非酒精性脂肪肝动物模型研究进展[J].河北医科大学学报,2007,28(1):67. |
[12] |
吴利春,尹梦,候梦莹,等.高脂联合地塞米松诱导小鼠急性脂肪肝模型的实验研究[J].重庆医学,2017(17):2383. |
[13] |
潘磊,张金彪,崔荣岗,等.非酒精性脂肪肝C57BL/6小鼠模型的建立[J].中国组织工程研究,2016,20(40):6054. |